3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
18
Carcinoma, Hepatocellular
9
Neoplasms
8
Melanoma
7
Squamous Cell Carcinoma of Head and Neck
6
Nasopharyngeal Carcinoma
6
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
5
Esophageal Neoplasms
5
Recurrence
4
Esophageal Squamous Cell Carcinoma
4
Colonic Neoplasms
4
Stomach Neoplasms
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Solid Cancers
2
Small Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Gastric / Gastroesophageal Junction Adenocarcinoma
2
EBV-associated Tumors
2
Cholangiocarcinoma
2
Breast Neoplasms
2
Bites and Stings
2
Biliary Tract Neoplasms
2
Advanced Solid Tumors
2
Interventions
Fluorouracil
8
Oxaliplatin
7
Surveys and Questionnaires
6
Leucovorin
6
Blood Specimen Collection
6
Specimen Handling
5
Gemcitabine
5
Cetuximab
5
Capecitabine
5
Bevacizumab
5
fludarabine
4
aldesleukin
4
Standard of Care
4
Cyclophosphamide
4
Remote Patient Monitoring
3
Radiosurgery
3
Pafolacianine
3
Nivolumab
3
Irinotecan
3
Endoscopic Mucosal Resection
3
Cisplatin
3
130-nm albumin-bound paclitaxel
3
encorafenib
2
Tomography, X-Ray Computed
2
Sunitinib
2
Referral and Consultation
2
Radiotherapy
2
Practice Guidelines as Topic
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Immune Checkpoint Inhibitors
×
1 year
×
Clear all
No trials found.